AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Thor Medical ASA

Report Publication Announcement Aug 22, 2025

3679_rns_2025-08-22_e9fc7e36-304f-412a-9bff-840ef1838a84.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00

Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00

22.8.2025 08:00:01 CEST | Thor Medical ASA | Non-regulatory press releases

Thor Medical ASA will present its financial results for the first half 2025 on

Friday 29 August 2025 at 08:00 am (CET) at Sjølyst Møtesenter, Drammensveien

165, and welcome investors, analysts and media to review the company's

achievements in the first half and its vision for the road ahead.

The interim financial report for the first half 2025 and the presentation

material will be released one hour earlier, at 07:00 (CET), and the material

will also be available on the company website at www.thormedical.com -

http://www.thormedical.com.

While Thor Medical encourages physical attendance, the presentation and Q&A

session will also be available through a live webcast at www.thormedical.com -

http://www.thormedical.com or through the following link: Thor Medical Webcast

1H 2025 - https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20250829_1

Contacts:

Brede Ellingsæter, CFO & COO, Thor Medical ASA, +47 472 38 440,

[email protected]

About Thor Medical:

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle

emitters, from naturally occurring thorium. Its proprietary production process

requires no irradiation or use of nuclear reactors, and provides reliable,

environmentally friendly, cost-efficient supply of alpha-emitters for the

radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and

listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn

more, visit www.thormedical.com - http://www.thormedical.com

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17848634/18627716/6362/Download%20announce

ment%20as%20PDF.pdf

Talk to a Data Expert

Have a question? We'll get back to you promptly.